COMTRADE-DIGITAL-SERVICE
5.12.2016 09:02:48 CET | Business Wire | Press release
Comtrade Digital Services , the leading software engineering services and solutions provider, today announced that it has created an automated banking platform for one of the world’s leading messaging apps, Viber. The transformative new solution is set to shake up the payments world, allowing users to carry out a range of banking transactions entirely through a chat-bot.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20161205005101/en/
With the tap of a finger, Viber users of participating banks will now be able to instantly send and transfer money. They will also be able to check their bank balance and access other banking services directly through the app. Recipients of Viber payments will be able to instantly retrieve the money sent to them by using a QR code at an ATM or going to their local branch.
Using agile methodologies, Comtrade Digital Services developed a banking solution with a chat-bot that can understand and process user requests instantly and securely. The product can be integrated directly with banks’ own digital platforms and will help them to compete with emerging Fintech companies. The solution also includes a client acquisition tool that will help banks attract younger customers, who will soon dominate the payments world. The project was completed in just three months.
The banking platform is part of Viber’s recently launched business-oriented platform, ‘Public Accounts’, which allows businesses, brands and individuals to interact with potential customers via the messaging app in a direct, personalised and intuitive manner.
Oliver Lynch, Business Development Director, Comtrade Digital Services, said: “This solution is going to transform the payments world for retail banks, payment processors and their customers. Most banks now have a mobile app, but they don’t provide such innovative, instant payment options as this. This is the only messaging platform that, through an API, can be directly integrated with banks’ existing digital banking channels.
“At Comtrade Digital Services, we are constantly telling businesses that they must be willing to embrace and drive digital transformation in order to stay ahead. That is exactly what Viber has done and I expect many will follow. This marks a whole new era of banking and we can expect a significant proportion of the world’s micro transactions to be carried out over messaging apps and social media platforms in the future.
“Now, it is time for the world’s banks to welcome this new era and seek innovative solutions that will help them retain and attract customers – or be left behind.”
Elad Kojocaru, VP Marketing, Viber, said: “Viber started out as an app that connects people. Now, we are introducing a way for people to start connecting with businesses and brands through the launch of our Public Accounts service. Thanks to innovative technology partners such as Comtrade Digital Services, we enable businesses from traditional industries, such as banking, to enter the instant messaging era and interact with their customers in new ways.”
- ends -
About Comtrade Digital Services
Comtrade Digital Services is part of Comtrade Group, a leading IT provider with offices in 11 countries across Europe and North America. The group was established in 1990 and operates through 16 companies with a global staff base of over 1,500.
Comtrade Digital Services is the trusted developer of some of the world’s most renowned businesses, providing end-to-end technology products and solutions across a number of industries including government, financial institutions, healthcare, mobility, travel and logistics. By providing strategic software engineering services, Comtrade Digital Services accelerates innovation and helps companies address business challenges, embrace digital transformation and become industry leaders.
For more information on Comtrade Digital Services, visit www.comtradedigital.com
About Viber
Part of the Rakuten family, Viber freely connects users around the world with the people that matter to them most. With more than 800 million unique users on the platform, Viber allows people to connect in the way that works best for them, whether that’s through individual messaging, video calls or group chats, or following brands and celebrities on Public Accounts. Viber can be used on iPhone® , iPad® , Android™ phones and tablets, Windows Phone, Windows® , Windows 8® , Mac, and Linux devices over mobile or WiFi connections.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161205005101/en/
Contact:
For Comtrade Digital Services
Helen Morrogh
Comit
Communications & Marketing
Tel: +353 1 2157677
Mob: +353
85 7814755
Email: helen@comit.ie
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
